Nuclear spin hyperpolarization of pyruvate enables longitudinal monitoring of treatment response in intestinal tumor organoids

Authors:

Josh P. Peters, Hang Xiang, Charbel D. Assaf, Farhad Haj Mohamad, Philip Rosenstiel, Stefan Schreiber, Jan-Bernd Hövener, Konrad Aden, Andrey N. Pravdivtsev

Year of publication:

2025

Volume:

94

Issue:

6

ISSN:

1522-2594

Journal (long):

Magnetic Resonance in Medicine

Journal (short):

Magn Reson Med

Impact factor:

3.2

Abstract:

Purpose: Colorectal cancer, a leading cause of death in the Western world, is increasingly affecting younger populations. The Warburg effect, characterized by enhanced lactate production, is a hallmark of this cancer type. Although 18F-FDG PET-CT is commonly used for diagnosis, MRI offers higher spatial and chemical resolution without the drawbacks of radiation. However, MRI’s low sensitivity has been a barrier to real-time metabolic imaging, and hence its implementation in clinical practice. Hyperpolarization has significantly boosted NMR sensitivity, enabling detailed metabolic studies in vivo.

Methods: This study uses hyperpolarized [1-13C]pyruvate with dissolution dynamic nuclear polarization to noninvasively monitor metabolic changes in intestinal organoids from a genetically defined mouse model of spontaneous carcinogenesis (Rnaseh2b/Xbp1ΔIEC) with a previously established targeted therapeutic intervention (mTOR inhibition by rapamycin).

Results: Hyperpolarized NMR revealed a 6.6-fold reduction (p < 0.05) in lactate production in rapamycin-treated organoids, indicating suppressed metabolic activity. This method also detected alanine and bicarbonate metabolism, highlighting its sensitivity. Unlike traditional methods that destroy cellular integrity, hyperpolarization enabled repetitive, noninvasive metabolic assessments. Conclusion: Hyperpolarized [1-13C]pyruvate combined with NMR enables noninvasive, longitudinal monitoring of tumor metabolism in intestinal organoids while preserving cell viability and recultivation potential, bridging preclinical and clinical applications and affirming the method's potential for targeted metabolic imaging as a novel diagnostic and treatment control approach in cancer medicine.

Participating Institutes